1
TÍTULO: Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting
AUTORES: Philipp Albrecht; Ingrid Kristine Bjorna; David Brassat; Rachel Farrell; Peter Feys; Jeremy Hobart; Raymond Hupperts; Michael Linnebank; Jozef Magdic; Celia Oreja Guevara; Carlo Pozzilli; Antonio Vasco Salgado; Tjalf Ziemssen;
PUBLICAÇÃO: 2018, FONTE: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, VOLUME: 11
INDEXADO EM: Scopus WOS
2
TÍTULO: The effect of prolonged-release fampridine treatment on health-related quality of life outcomes after 1 year: results from the ENABLE study  Full Text
AUTORES: Sorensen, PS; Macdonell, R; Pozzilli, C; Nagels, G; Laplaud, D; de Jong, B; Silva, AM; Nicholas, R; Gaebler, JA; Agarwal, S; Wang, P;
PUBLICAÇÃO: 2014, FONTE: Joint Congress of European Neurology in JOURNAL OF NEUROLOGY, VOLUME: 261
INDEXADO EM: WOS
3
TÍTULO: The effect of prolonged-release fampridine treatment on health-related quality of life outcomes after 1 year: results from the ENABLE study  Full Text
AUTORES: Sorensen, PS; Macdonell, R; Pozzilli, C; Nagels, G; Laplaud, D; de Jong, B; Silva, AM; Nicholas, R; Gaebler, JA; Agarwal, S; Wang, P;
PUBLICAÇÃO: 2014, FONTE: Joint Congress of European Neurology in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 21
INDEXADO EM: WOS
4
TÍTULO: Health-related quality of life outcomes following long-term treatment with prolonged-release fampridine: impact on psychological outcomes in the ENABLE study  Full Text
AUTORES: Pozzilli, C; Macdonell, R; Sorensen, PS; Nagels, G; Laplaud, D; de Jong, B; Martins Silva, AM; Nicholas, R; Gaebler, J; Sun, J;
PUBLICAÇÃO: 2013, FONTE: 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS in MULTIPLE SCLEROSIS JOURNAL, VOLUME: 19, NÚMERO: 11
INDEXADO EM: WOS